Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Current Leases: 2019-2024

Historic Current Leases for Viking Therapeutics (VKTX) over the last 6 years, with Dec 2024 value amounting to $489,000.

  • Viking Therapeutics' Current Leases fell 8.96% to $437,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $437,000, marking a year-over-year decrease of 8.96%. This contributed to the annual value of $489,000 for FY2024, which is 50.93% up from last year.
  • As of FY2024, Viking Therapeutics' Current Leases stood at $489,000, which was up 50.93% from $324,000 recorded in FY2023.
  • Viking Therapeutics' 5-year Current Leases high stood at $489,000 for FY2024, and its period low was $29,000 during FY2021.
  • Over the past 3 years, Viking Therapeutics' median Current Leases value was $324,000 (recorded in 2023), while the average stood at $372,333.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 91.21% in 2021, then spiked by 948.28% in 2022.
  • Over the past 5 years, Viking Therapeutics' Current Leases (Yearly) stood at $330,000 in 2020, then slumped by 91.21% to $29,000 in 2021, then soared by 948.28% to $304,000 in 2022, then climbed by 6.58% to $324,000 in 2023, then spiked by 50.93% to $489,000 in 2024.